The AstraZeneca PLC ADR
shed 1.14% to $50.21 Friday, on what proved to be an all-around poor buying and selling session for the stock market, with the NASDAQ Composite Index
falling 0.07% to 12,755.64 and Dow Jones Industrial Common
falling 0.41% to 30,179.05. This was the ADR’s second consecutive day of losses. AstraZeneca PLC ADR closed $14.73 wanting its 52-week excessive ($64.94), which the corporate achieved on July 20th.
The ADR demonstrated a blended efficiency when in comparison with a few of its opponents Friday, as AbbVie Inc.
fell 0.42% to $104.45, Amgen Inc.
fell 1.19% to $228.49, and Gilead Sciences Inc.
rose 0.02% to $59.08. Buying and selling quantity (25.7 M) eclipsed its 50-day common quantity of seven.6 M.
Editor’s Notice: This story was auto-generated by Automated Insights utilizing knowledge from Dow Jones and FactSet. See our market knowledge phrases of use.